Key result
Surgical resection and SVG bypass successfully treat a giant RCA aneurysm causing cardiac compression.
Case Report (n=1)
No
Surgical resection with concurrent coronary artery bypass grafting is a safe and effective treatment for giant coronary artery aneurysms presenting with cardiac compression.
Giant coronary aneurysms merit consideration in atypical chest pain with compression; extends phenotypic spectrum but leaves management strategies open.
Here, we report a case of a 53-year-old woman without traditional cardiovascular risk factors who presented with acute chest pain and signs of right heart compression and superior vena cava syndrome. Multimodal imaging, including computed tomography angiography, cardiac magnetic resonance, and echocardiography, revealed a giant right coronary artery aneurysm with a maximum diameter of approximately 15.6 cm, containing a large amount of intraluminal thrombus and causing compression of the right atrium, right ventricle, and superior vena cava. Serological and pathological examinations ruled out vasculitic diseases, while histopathology of the aneurysmal wall revealed fibrous hyperplasia, architectural disorganization, and hyalinization, suggesting non-atherosclerotic, non-inflammatory arterial wall degeneration with an unclear origin. The patient underwent successful aneurysm resection, thrombus evacuation, proximal and distal ligation of the right coronary artery, and concurrent distal bypass grafting using a saphenous vein graft. Postoperatively, the central venous pressure decreased significantly, the clinical symptoms resolved rapidly, and the graft remained patent at the 3-month follow-up.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2026) conducted a case report in Giant coronary artery aneurysm (n=1). Surgical resection and saphenous vein bypass grafting was evaluated on Clinical recovery and graft patency. Surgical resection and concurrent saphenous vein bypass grafting successfully treated a giant right coronary artery aneurysm causing cardiac compression, with the graft remaining patent at 3-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: